Neuroblastoma is the most common extracranial solid tumor found in children and accounts for 13-15% of all pediatric cancer deaths. Amplification of MycN is one of the strongest indicators of poor prognosis and is present in 50% of all high-risk cases of neuroblastoma; its role in neuroblastoma has not been clearly elucidated, but evidence suggests that it binds to the C-terminal domain of p53 and alters its response to genotoxic stress. The binding of p53 and MycN is a novel discovery; more investigation into the role of p53-MycN binding can provide insight into neuroblastoma tumorigenesis and potentially other MycN-amplified cancers. This project sought to further investigate the role of MycN and p53 binding in neuroblastoma and to outline further research on the novel interaction.

• This report represents the work of one or more WPI undergraduate students submitted to the faculty as evidence of completion of a degree requirement. WPI routinely publishes these reports on its website without editorial or peer review.

Creator

• Honzel, Brooke E.

Publisher

• Worcester Polytechnic Institute

Identifier

• E-project-051320-033719

Advisor

• Manning, Amity L.

Year

• 2020

Sponsor

• University of Massachusetts Medical School

Date created

• 2020-05-13

Resource type

• Major Qualifying Project

Major

• Biology & Biotechnology

Rights statement

• In Copyright